MDIF 2012 - New Frontiers in Ophthalmology: Clinical and Investor Perspectives
This panel discussed Orange Countyâ€™s preeminence as the global technology development epicenter and specific technology advances that are shaping both the clinical and investment worlds in ophthalmology.
Dr. Steinert presented the technology advances that are shaping the world of ophthalmology from a clinical perspective. Dr. Link subsequently presented the current state of affairs for investments in ophthalmology and some of the most promising technologies. Finally, the two presentations were followed with a moderated discussion between these two Orange County luminaries and Matthew Jenusaitis, CEO of OCTANe.